Early Access — free while we kick the tires
EdgarHawk

Eric Warren

Chief Commercial Officer

Officer

Latest: Chief Commercial Officer selling · June 2026

1 filing analyzed · 1 company · Latest 2026-06-30

Never miss a filing from Eric Warren

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
Mineralys Therapeutics, Inc. MLYS 0 2 Net selling

Activity

June 2026
high
Sell
104,124 shares
$2,696,322
Significance 6/10

Chief Commercial Officer Eric Warren sold 104,124 shares of MLYS at $25.90 via 10b5-1 plan adopted 2026-03-27; retains 38,400 shares plus 252,876 stock options.

Eric Warren, Chief Commercial Officer, executed a scheduled sale of 104,124 shares for $2,696,322.22 under a pre-arranged 10b5-1 trading plan adopted on 2026-03-27—this is a non-discretionary, planned transaction. His non-derivative holdings fell to 38,400 shares from 142,524 shares, but he retains 252,876 stock options in derivative form, maintaining material exposure to the company. The sale occurred at $25.90, and the stock currently trades at $26.98, down -43.4% from its 52-week high of $47.65; this timing reflects the plan's adoption date (March 2026), not active market timing. Most critically, the company reported a full-year net income of -$39,339,000.00, indicating sustained unprofitability during the period leading up to plan adoption, which provides context for when this scheduled liquidation was locked in.

Related insiders